对活体重组BCG-HIV疫苗的幽默和细胞介导免疫反应
1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142.
Nature
|June 6, 1991
概括
这项研究表明,结核疫苗Mycobacterium bovis bacillus Calmette-Guerin (BCG) 可以通过基因改造来表达外来蛋白质,例如来自HIV-1的蛋白质. 这些修改后的BCG疫苗可以有效触发免疫反应,为新疫苗开发铺平道路.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 微生物遗传学微生物遗传学
- 免疫学 免疫学 免疫学
背景情况:
- 活体重组疫苗提供了一种有前途的新一代针对传染病的疫苗.
- 人类结核病疫苗Mycobacterium bovis bacillus Calmette-Guerin (BCG) 是活体重组疫苗载体的强有力的候选者,因为它具有辅助性质,安全记录和已建立的全球分布.
- 菌根菌分子遗传工具的进步使得外来基因可以被引入BCG.
研究的目的:
- 调查BCG作为活体重组疫苗载体的潜力.
- 为了证明BCG中外来抗原的表达,并评估由此产生的免疫反应.
主要方法:
- 用基因工程改造的BCG重组剂以表达人体免疫缺陷病毒1型 (HIV-1) 聚,使用菌根细菌的hsp70促进体.
- 评估了BCG内部的外来多的生产情况.
- 评估了这些重组BCG在体内诱导抗体和T细胞反应的能力.
主要成果:
- 在BCG复合剂中成功表达了各种HIV-1多.
- 证实BCG产生的外来多可以引起特定抗体和T细胞介导的免疫反应.
- 证明BCG能够作为诱导对病原体蛋白质免疫力的载体.
结论:
- BCG是一种可行的和有效的活体重组疫苗载体.
- 这种方法可以诱导针对目标病原体的保护性免疫反应,为针对HIV-1等传染病的疫苗开发提供了一种新的策略.
相关概念视频
Cell-mediated Immune Responses
Overview
Vaccinations
Overview
B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...


